WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2014

Mar 3, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2014-02-28

Reporting Person: Lennartz Heino (President Europe)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-02-28	Common Stock	M	9485.0000	$21.2200	Acquired	37606.0586	Direct
2014-02-28	Common Stock	M	6586.0000	$29.5550	Acquired	44192.0586	Direct
2014-02-28	Common Stock	S	16044.0000	$45.8370	Disposed	28148.0586	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-02-28	Stock Option (Right to Buy)	$29.5550	M	6586.0000	Disposed	2023-02-19	Common Stock (6586.0000)	Direct
2014-02-28	Stock Option (Right to Buy)	$21.2200	M	9485.0000	Disposed	2022-02-21	Common Stock (9485.0000)	Direct